True North Advisors’s BioHarvest Sciences BHST Stock Holding History

True North Advisors’s Portfolio BHST Stock Details BHST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$536K	Buy	187,318 +19,305	+11%	+$73.7K	0.05%	171
2026 Q1	$729K	Buy	168,013 +133,085	+381%	+$627K	0.08%	134
2025 Q4	$181K	Sell	34,928 -133,085	-79%	-$1.06M	0.02%	249
2025 Q3	$1.58M	Buy	168,013 +146,365	+676%	+$1.2M	0.25%	65
2025 Q2	$146K	Sell	21,648 -22,743	-51%	-$146K	0.03%	220
2025 Q1	$275K	Buy	44,391 +3,120	+8%	+$17.9K	0.05%	205
2024 Q4	$255K	Buy	+41,271	New	+$254K	0.06%	163

Other funds holding BHST

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

EWM

Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

True North Advisors's BHST Position: Q2 2026 in Review

True North Advisors increased its BioHarvest Sciences (BHST) stake by 11% in Q2 2026, buying an estimated $73.7K and bringing the position to 187,318 shares worth $536K. The position accounts for 0.05% of the portfolio, ranked #171.

True North Advisors first reported a position in BHST in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.58M in Q3 2025. 19 funds tracked by Wall St. Rank hold BHST as of Q2 2026.

True North Advisors held 187,318 shares of BioHarvest Sciences worth $536K as of Q2 2026.
True North Advisors bought 19,305 BioHarvest Sciences shares in Q2 2026, an estimated $73.7K.
BioHarvest Sciences made up 0.05% of True North Advisors's portfolio in Q2 2026, its #171 holding.
True North Advisors first reported a position in BioHarvest Sciences in Q4 2024 and has held it in 7 quarters since.
True North Advisors's BioHarvest Sciences position peaked at $1.58M in Q3 2025.
19 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.